v3.25.2
Document and Entity Information - USD ($)
$ in Millions
 12 Months Ended
Apr. 30, 2025
Jul. 23, 2025
Oct. 31, 2024
Document Information [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Period End Date Apr. 30, 2025    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Entity Registrant Name HEARTSCIENCES INC.    
Entity Central Index Key 0001468492    
Current Fiscal Year End Date --04-30    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period false    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Entity File Number 001-41422    
Entity Incorporation, State or Country Code TX    
Entity Tax Identification Number 26-1344466    
Entity Address, Address Line One 550 Reserve Street    
Entity Address, Address Line Two Suite 360    
Entity Address, City or Town Southlake    
Entity Address, State or Province TX    
Entity Address, Postal Zip Code 76092    
City Area Code 682    
Local Phone Number 237-7781    
Entity Common Stock, Shares Outstanding   1,934,280  
Entity Public Float     $ 5.4
Document Annual Report true    
Document Transition Report false    
Auditor Firm ID 200    
Auditor Name HASKELL & WHITE LLP    
Auditor Location Irvine, California    
Document Financial Statement Error Correction [Flag] false    
Auditor Opinion

Opinion on the Financial Statements

We have audited the accompanying balance sheets of HeartSciences Inc. (the “Company”) as of April 30, 2025 and 2024, the related statements of operations, stockholders’ equity, and cash flows for each of the two years in the period ended April 30, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of April 30, 2025 and 2024, and the results of its operations and its cash flows for each of the two years in the period ended April 30, 2025, in conformity with U.S. generally accepted accounting principles.

    
Common Stock      
Document Information [Line Items]      
Title of 12(b) Security Common Stock    
Trading Symbol HSCS    
Security Exchange Name NASDAQ    
Warrants      
Document Information [Line Items]      
Title of 12(b) Security Warrants    
Trading Symbol HSCSW    
Security Exchange Name NASDAQ